MEHLMAN CONSULTING, INC. for MAYO CLINIC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
Reimbursement issues. Meetings with Members of Congress regarding Mayos role in supporting VAs efforts to modernize agreements with community providers of care to veterans.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON | — |
| MCKENZIE BRICE | — |
| DAVID CASTAGNETTI | — |
| NICHOLE DISTEFANO | — |
| SAGE EASTMAN | — |
| ELISE FINLEY PICKERING | — |
| STEVE HARO | — |
| CONSTANTINE HINGSON | — |
| BRUCE MEHLMAN | — |
| MICHAEL ROBINSON | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| PAUL THORNELL | — |
| HELEN TOLAR | — |
Health Issues HCR
General healthcare; health reform; healthcare value and quality; health information technology; clinical trials; tele-health; healthcare costs; healthcare interoperability. Promoting biomedical research. Opioid addiction and treatment. S. 1895: Lower Health Care Costs Act. Patent issues impacting clinical laboratory innovation. Clinical laboratory capacity and reimbursement issues. Financial support for providers for diagnosis and treatment related to COVID-19, coverage of COVID-19 related conditions, access to PPE and other materials and equipment related to the treatment of patients with COVID-19. H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136 H.R. 266, Paycheck Protection Program and Health Care Enhancement Act Implementation. H.R. 6800, HEROES Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON | — |
| MCKENZIE BRICE | — |
| DAVID CASTAGNETTI | — |
| NICHOLE DISTEFANO | — |
| SAGE EASTMAN | — |
| ELISE FINLEY PICKERING | — |
| STEVE HARO | — |
| CONSTANTINE HINGSON | — |
| BRUCE MEHLMAN | — |
| MICHAEL ROBINSON | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| PAUL THORNELL | — |
| HELEN TOLAR | — |
Medicare/Medicaid MMM
General healthcare; health reform; healthcare value and quality; health information technology; clinical trials; tele-health; healthcare costs; healthcare interoperability. Promoting biomedical research. Opioid addiction and treatment. Rural health. Clinical laboratory capacity and reimbursement issues. Financial support for providers for diagnosis and treatment related to COVID-19, coverage of COVID-19 related conditions, access to PPE and other materials and equipment related to the treatment of patients with COVID-19.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON | — |
| MCKENZIE BRICE | — |
| DAVID CASTAGNETTI | — |
| NICHOLE DISTEFANO | — |
| SAGE EASTMAN | — |
| ELISE FINLEY PICKERING | — |
| STEVE HARO | — |
| CONSTANTINE HINGSON | — |
| BRUCE MEHLMAN | — |
| MICHAEL ROBINSON | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| PAUL THORNELL | — |
| HELEN TOLAR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.